In a clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) it was shown that a new treatment for multiple sclerosis (MS) held promise and performed better than existing treatments. In the trial the patients were given a high-dose immunosuppressive therapy which was followed by transplanting the stem cells in their blood back into their bodies. The result was a long-term sustained remission in 69% of the patients MS disease and symptoms. Multiple sclerosis is an autoimmune disease in which the patients central nervous system is attacked by its immune system.Find him on Facebook : https://www.facebook.com/shivagopalvasishta
The results of the study showed that five years after treatment the patients who it was successful with had experienced no progression in the disease, new brain lesions, or a relapse of their symptoms. Symptoms of MS include weakness, motor and speech difficulties, chronic pain, and fatigue.Dr. Anthony Fauci, Director of the NIAID, said that the findings of the trial suggest that this treatment may be much more effective than present long-term treatment options and the results were encouraging. Some patients even showed improvements in their symptoms such as a recovery of mobility and lessening of chronic pain.
Dr. Shiva Gopal Vasishta has been treating MS patients for almost 40 years. Dr. Shiva GopalVasishta’s specialties are Neurology and Psychiatry which he learned at Government Medical College in Nagpur, India. Dr. Vasishta is affiliated with Kennedy University Hospital along with 34 other who specialize in Neurology.The practice where Dr. Shiva GopalVasishta treats his patients in Eastern NeurodiagnosticAssoc PC which is located in Voorhees, New Jersey. Dr. Shiva GopalVasishta accepts Aetna, Blude Cross Blue Shield, and Medicare policies.